Publications
- Epidemiology of non-Hodgkin's lymphomas in Czech Republic, Europe and North America +12009 | Publication without faculty affiliation
- Does exist any standards of care in lymphoma patients? +12008 | Publication without faculty affiliation
- Diagnostic and therapeutical algorithms in lymphoma patients II2007 | Publication without faculty affiliation
- The non-Hodkgin's lymphoma subtypes distribution and survival in Czech Republic +12007 | Publication without faculty affiliation
- Anagrelide in trealment of ET and MPS with trombocytemia in Czech Republic +12006 | Faculty of Medicine in Hradec Králové
- Anagrelide in trealment of ET and MPS with trombocytemia in Czech Republic +1Publication without faculty affiliation
- Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study2024 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
Loading network view...
